The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study

Cell salvage is an important component of blood management in patients undergoing revision hip arthroplasty surgery. However concerns regarding efficacy and patient selection remain. The aims of this study were to describe intra‐operative blood loss, cell salvage re‐infusion volumes and red blood ce...

Full description

Bibliographic Details
Main Authors: Palmer, AJR, Lloyd, TD, Gibbs, VN, Shah, A, Dhiman, P, Booth, R, Murphy, MF, Taylor, AH, Kendrick, BJL
Format: Journal article
Language:English
Published: Wiley 2020
_version_ 1797071100261171200
author Palmer, AJR
Lloyd, TD
Gibbs, VN
Shah, A
Dhiman, P
Booth, R
Murphy, MF
Taylor, AH
Kendrick, BJL
author_facet Palmer, AJR
Lloyd, TD
Gibbs, VN
Shah, A
Dhiman, P
Booth, R
Murphy, MF
Taylor, AH
Kendrick, BJL
author_sort Palmer, AJR
collection OXFORD
description Cell salvage is an important component of blood management in patients undergoing revision hip arthroplasty surgery. However concerns regarding efficacy and patient selection remain. The aims of this study were to describe intra‐operative blood loss, cell salvage re‐infusion volumes and red blood cell transfusion rates for revision hip procedures and to identify factors associated with the ability to salvage sufficient blood intra‐operatively to permit processing and re‐infusion. Data were collected from a prospective cohort of 664 consecutive patients undergoing revision hip surgery at a single tertiary centre from 31 March 2015 to 1 April 2018. Indications for revision surgery were aseptic (n = 393 (59%)) fracture (n = 160 (24%)) and infection (n = 111 (17%)). Salvaged blood was processed and re‐infused when blood loss exceeded 500 ml. Mean (SD ) intra‐operative blood loss was 1038 (778) ml across all procedures. Salvaged blood was re‐infused in 505 of 664 (76%) patients. Mean (SD ) re‐infusion volume was 253 (169) ml. In total, 246 of 664 (37%) patients received an allogeneic red blood cell transfusion within 72 h of surgery. Patients undergoing femoral component revision only (OR (95%CI ) 0.41 (0.23–0.73)) or acetabular component revision only (0.53 (0.32–0.87)) were less likely to generate sufficient blood salvage volume for re‐infusion compared with revision of both components. Compared with aseptic indications, patients undergoing revision surgery for infection (1.87 (1.04–3.36)) or fracture (4.43 (2.30–8.55)) were more likely to generate sufficient blood salvage volume for re‐infusion. Our data suggest that cell salvage is efficacious in this population. Cases where the indication is infection or fracture and where both femoral and acetabular components are to be revised should be prioritised.
first_indexed 2024-03-06T22:48:23Z
format Journal article
id oxford-uuid:5df9bb60-978f-411a-abf3-e80b1c0c742a
institution University of Oxford
language English
last_indexed 2024-03-06T22:48:23Z
publishDate 2020
publisher Wiley
record_format dspace
spelling oxford-uuid:5df9bb60-978f-411a-abf3-e80b1c0c742a2022-03-26T17:37:40ZThe role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5df9bb60-978f-411a-abf3-e80b1c0c742aEnglishSymplectic Elements at OxfordWiley2020Palmer, AJRLloyd, TDGibbs, VNShah, ADhiman, PBooth, RMurphy, MFTaylor, AHKendrick, BJLCell salvage is an important component of blood management in patients undergoing revision hip arthroplasty surgery. However concerns regarding efficacy and patient selection remain. The aims of this study were to describe intra‐operative blood loss, cell salvage re‐infusion volumes and red blood cell transfusion rates for revision hip procedures and to identify factors associated with the ability to salvage sufficient blood intra‐operatively to permit processing and re‐infusion. Data were collected from a prospective cohort of 664 consecutive patients undergoing revision hip surgery at a single tertiary centre from 31 March 2015 to 1 April 2018. Indications for revision surgery were aseptic (n = 393 (59%)) fracture (n = 160 (24%)) and infection (n = 111 (17%)). Salvaged blood was processed and re‐infused when blood loss exceeded 500 ml. Mean (SD ) intra‐operative blood loss was 1038 (778) ml across all procedures. Salvaged blood was re‐infused in 505 of 664 (76%) patients. Mean (SD ) re‐infusion volume was 253 (169) ml. In total, 246 of 664 (37%) patients received an allogeneic red blood cell transfusion within 72 h of surgery. Patients undergoing femoral component revision only (OR (95%CI ) 0.41 (0.23–0.73)) or acetabular component revision only (0.53 (0.32–0.87)) were less likely to generate sufficient blood salvage volume for re‐infusion compared with revision of both components. Compared with aseptic indications, patients undergoing revision surgery for infection (1.87 (1.04–3.36)) or fracture (4.43 (2.30–8.55)) were more likely to generate sufficient blood salvage volume for re‐infusion. Our data suggest that cell salvage is efficacious in this population. Cases where the indication is infection or fracture and where both femoral and acetabular components are to be revised should be prioritised.
spellingShingle Palmer, AJR
Lloyd, TD
Gibbs, VN
Shah, A
Dhiman, P
Booth, R
Murphy, MF
Taylor, AH
Kendrick, BJL
The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study
title The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study
title_full The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study
title_fullStr The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study
title_full_unstemmed The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study
title_short The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study
title_sort role of intra operative cell salvage in patient blood management for revision hip arthroplasty a prospective cohort study
work_keys_str_mv AT palmerajr theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT lloydtd theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT gibbsvn theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT shaha theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT dhimanp theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT boothr theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT murphymf theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT taylorah theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT kendrickbjl theroleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT palmerajr roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT lloydtd roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT gibbsvn roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT shaha roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT dhimanp roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT boothr roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT murphymf roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT taylorah roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy
AT kendrickbjl roleofintraoperativecellsalvageinpatientbloodmanagementforrevisionhiparthroplastyaprospectivecohortstudy